Bifidobacterium infantis M-63: Superior Probiotic for Infant Use

Bifidobacterium longum subspecies infantis M-63 stands out among gut bacteria for its exceptional ability to utilize human milk oligosaccharides (HMOs), a component abundantly found in human breast milk. HMOs offer no direct nutritive value for infants, but they play a crucial role in shaping a healthy infant gut microbiota with life-long impacts. M-63 possesses superior potential to colonize and adapt to the human intestinal environment, particularly in infants. M-63 is recognized as a probiotics strain that is well-adapted to the intestinal environment of humans, especially infants. Ingestion of M-63 is specifically effective in enhancing the colonization of bifidobacteria in the infant gut, with potential benefits for gut health and overall well-being.